Otoraplin, a protein encoded by the gene OTOR, is primarily expressed in the inner ear and is associated with the physiology of hearing. As part of the otolin family of proteins, otoraplin is found in the otolithic membranes of the vestibular system, which is responsible for maintaining balance and spatial orientation. The otolithic membranes are gelatinous layers that contain calcium carbonate crystals called otoconia; otoraplin is thought to play a role in their development and maintenance.
The otolithic organs, consisting of the utricle and saccule, are sensitive to head movements and gravitational forces due to their unique structure, where the otoconia add mass to the otolithic membranes. Otoraplin, along with other matrix proteins, contributes to the proper structure and function of these membranes. It is believed that otoraplin interacts with other extracellular matrix components, providing structural integrity and contributing to the biophysical properties required for the otolithic membranes to respond to accelerations and tilts of the head.Although the precise biochemical function of otoraplin is not fully understood, its expression pattern suggests that it may be critical in the formation or stabilization of otoconia. Otoconia abnormalities can lead to vestibular disorders, such as benign paroxysmal positional vertigo (BPPV), where dislodged otoconia can cause dizziness and a spinning sensation. Studying otoraplin and its interactions within the otolithic membrane could provide insights into the pathophysiology of such vestibular conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly influences OTOR activity by elevating cAMP levels, which can modulate various signaling pathways that OTOR may be a part of. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) enhances intracellular cAMP by inhibiting phosphodiesterases, potentially affecting OTOR-related pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid affects gene expression and could modulate the expression or activity of OTOR in certain cell types. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
As a glucocorticoid, Dexamethasone can alter gene expression and may indirectly affect OTOR activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride activates the Wnt/beta-catenin pathway, potentially influencing OTOR-related processes. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
Transforming growth factor-beta1 is involved in cellular processes that could intersect with OTOR's function. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 influences various inflammatory and healing processes, potentially affecting OTOR activity. | ||||||